Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer

Urologia Internationalis

Volumn 78, Issue 4, 2007, Pages 313-317

  Stamatiou, Konstantinos ^a,b   Alevizos, Alevizos ^a,b,c,e   Karanasiou, Vasilisa ^d   Mariolis, Anargiros ^b   Mihas, Constantinos ^b   Papathanasiou, Marek ^b,c   Bovis, Konstantinos ^c   Sofras, Frangiskos ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b Health Center of Vyronas   (Greece)

^c TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^d General Hospital of Thiva   (Greece)

^e NONE   (Greece)

Author keywords

Prostate biopsy; Transrectal ultrasound; Ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER PATIENT; CHRONIC PROSTATITIS; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROSTATE STONE; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; STONE FORMATION; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 34248168724     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100834     Document Type: Article

References (29)

1. Hodge KK, McNeal JE, Terris MK, Stamey TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-75.
2. Levine MA, Ittman M, Melamed J, Lepor H: Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998;159:471-476.
3. Steven D, McCabe K, Peretsman S, Klein E, Levin H, Optenberg S, et al: Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer. J Urol 1998;159:1606-1608.
4. Chen ME, Troncoso P, Johnston DA, et al: Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997;158:2168-2175.
5. Eskew LA, Bare RL, McCullough DL: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157:199-202.
6. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K: The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000;163:166-167.
7. Terris MK: Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report. Urology 1999;54:486-489.
8. Babaian RJ, Toi A, Kamoi K, Troncoso P, Sweet J, Evans R, et al: A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000;163:152-157.
9. Xia SJ, Xu XX, Teng JB, Xu CX, Tang XD: Characteristic pattern of human prostatic growth with age. Asian J Androl 2002;4:269-271.
10. Chang JJ, Shinohara K, Bhargava V, Presti JC Jr: Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 1998;160:2111-2114.
11. Hodge KK, McNeal JE, Stamey TA: Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 1989b;142:66-70.
12. Littrup PJ, Bailey SE: Prostate cancer: The role of transrectal ultrasound and its impact on cancer detection and management. Radiol Clin N Am 2000;38:87-113.
13. Stamey TA: Making the most out of six systematic sextant biopsies. Urology 1995;45:2-12.
14. Chang JJ, Shinohara K, Hovey RM, et al: Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection. Urology 1998;52:89-93.
15. Daneshgari F, Taylor GD, Miller GJ, Crawford ED: Computer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsies. Urology 1995;45:604-609.
16. Naughton CK, Smith DS, Humphrey PA, Catalona WJ, Keetch DW: Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. Urology 1998;52:808-813.
17. Svetec D, McCabe K, Peretsman S, Klein E, Levin H, Optenberg S, et al: Prostate rebiopsy is a poor surrogate of treatment efficacy in localised prostate cancer. J Urol 1998;159:1606-1608.
18. Fink KG, Hutarew G, Pytel A, Esterbauer B, Jungwirth A, Dietze O, et al: One 10-core prostate biopsy is superior to two sets of sextant prostate biopsies. BJU Int 2003;92:385-388.
19. Eskicorapci SY, Baydar DE, Akbal C, Sofikerim M, Gunay M, Ekici S, et al: An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer. Eur Urol 2004;45:444-449.
20. Eskew LA, Bare RL, McCullough DL: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157:199-202.
21. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, et al: Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol 2004;171:1089-1092.
22. Philip J, Ragavan N, Desouza J, Foster CS, Javle P: Effect of peripheral biopsies in maximizing early prostate cancer detection in 8-, 10- or 12-core biopsy regimens. BJU Int 2004;93:1218-1220.
23. Babaian RJ: Extended field prostate biopsy enhances cancer detection. Urology 2000;55:453-456.
24. Terris MK: Extended field prostate biopsies: too much of a good thing? Urology 2000;55:457-460.
25. Anast JW, Andriole GL, Bismar TA, Yan Y, Humphrey PA: Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population? Urology 2004;64:544-550.
26. Terris MK, Wallen E, Stamey TA: Comparison of lateral versus midlobe systematic sextant biopsies in the detection of prostate cancer. Urol Int 1997c;59:239-242.
27. Durkan GC, Sheikh N, Johnson P, Hildreth AJ, Greene DR: Improving prostate cancer detection with an extended-core transrectal ultrasonography- guided prostate biopsy protocol. BJU Int 2002;89:33-39.
28. Epstein JI, Walsh PC, Carmichael M, Brendler CB: Pathologic and clinical findings to predict tumour extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271:368-374.
29. Crawford ED, Hirano D, Werahera PN, Lucia MS, DeAntoni EP, Daneshgari F, et al: Computer modelling of prostate biopsy: tumour size and location - not clinical significance - determine cancer detection. J Urol 1998;159:1260-1264.